Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.34% |
| 3 | Industrials | 11.14% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2301
Fifth District Bancorp
FDSB
$90.7M
| $948K | ﹤0.01% |
63,956
+635
| +1% | +$9.49K |
2025 Q3
2 quarters
|
|
2302
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $947K | ﹤0.01% |
3,836,665
-4,593,658
| -54% | -$1.83M |
2020 Q3
22 quarters
|
|
2303
NLI Holdings
NL
$339M
| $947K | ﹤0.01% |
162,470
+22,456
| +16% | +$135K |
2014 Q4
45 quarters
|
|
2304
Lesaka Technologies
LSAK
$402M
| $946K | ﹤0.01% |
185,900
+26,500
| +17% | +$125K |
2013 Q2
51 quarters
|
|
2305
Noah Holdings
NOAH
$520M
| $945K | ﹤0.01% |
95,500
+54,400
| +132% | +$624K |
2021 Q4
17 quarters
|
|
2306
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$3.51B
| $945K | ﹤0.01% |
38,900
+19,900
| +105% | +$435K |
2025 Q2
3 quarters
|
|
2307
Prelude Therapeutics
PRLD
$310M
| $941K | ﹤0.01% |
275,200
+3,900
| +1% | +$10.2K |
2021 Q4
17 quarters
|
|
2308
Rimini Street
RMNI
$388M
| $940K | ﹤0.01% |
286,526
-12,700
| -4% | -$44.1K |
2018 Q3
30 quarters
|
|
2309
State Street SPDR S&P Dividend ETF
SDY
$20.7B
| $934K | ﹤0.01% |
+6,400
| New | +$954K |
2026 Q1
0 quarters
|
|
2310
C3.ai
AI
$1.85B
| $934K | ﹤0.01% |
+110,900
| New | +$1.19M |
2026 Q1
0 quarters
|
|
2311
Telesat
TSAT
$699M
| $933K | ﹤0.01% |
25,763
-30,037
| -54% | -$966K |
2025 Q1
4 quarters
|
|
2312
CPS Technologies
CPSH
$68.6M
| $931K | ﹤0.01% |
248,958
+29,100
| +13% | +$129K |
2021 Q1
20 quarters
|
|
2313
Direxion Daily MSFT Bull 2X ETF
MSFU
$551M
| $927K | ﹤0.01% |
+40,300
| New | +$1.23M |
2026 Q1
0 quarters
|
|
2314
Niu Technologies
NIU
$155M
| $925K | ﹤0.01% |
320,000
-224,400
| -41% | -$745K |
2021 Q4
17 quarters
|
|
2315
Global X US Infrastructure Development ETF
PAVE
$13.7B
| $925K | ﹤0.01% |
+18,200
| New | +$948K |
2026 Q1
0 quarters
|
|
2316
Distribution Solutions Group
DSGR
$1.62B
| $921K | ﹤0.01% |
35,100
-9,600
| -21% | -$269K |
2014 Q3
46 quarters
|
|
2317
Triple Flag Precious Metals
TFPM
$6.43B
| $919K | ﹤0.01% |
26,481
+7,981
| +43% | +$289K |
2022 Q3
14 quarters
|
|
2318
iShares Intermediate Government/Credit Bond ETF
GVI
$3.74B
| $917K | ﹤0.01% |
+8,600
| New | +$923K |
2026 Q1
0 quarters
|
|
2319
BridgeBio Oncology
BBOT
$265M
| $912K | ﹤0.01% |
101,900
+27,600
| +37% | +$296K |
2025 Q4
1 quarter
|
|
2320
Zone Frontier Inc.
ZONE
$66.4M
| $911K | ﹤0.01% |
2,557,895
-2,881,091
| -53% | -$979K |
2025 Q4
1 quarter
|
|
2321
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$2.85B
| $911K | ﹤0.01% |
+20,100
| New | +$922K |
2026 Q1
0 quarters
|
|
2322
Contineum Therapeutics
CTNM
$503M
| $906K | ﹤0.01% |
69,400
+12,300
| +22% | +$165K |
2025 Q2
3 quarters
|
|
2323
Septerna Inc
SEPN
$1.79B
| $906K | ﹤0.01% |
+37,700
| New | +$991K |
2026 Q1
0 quarters
|
|
2324
Legacy Education Inc
LGCY
$131M
| $901K | ﹤0.01% |
72,000
+33,628
| +88% | +$397K |
2024 Q4
5 quarters
|
|
2325
HBT Financial
HBT
$1.27B
| $899K | ﹤0.01% |
33,651
-15,949
| -32% | -$434K |
2024 Q1
8 quarters
|
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.